ArticleMolecules (Basel, Switzerland)2022

Combined Treatment with PI3K Inhibitors BYL-719 and CAL-101 Is a Promising Antiproliferative Strategy in Human Rhabdomyosarcoma Cells.

Manuela Piazzi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.